Brussels, Belgium

Bruno LeClercq

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Bruno LeClercq

Introduction

Bruno LeClercq is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of pharmaceutical excipients, holding a total of 4 patents. His work focuses on improving the formulation of solid dosage forms, which are essential in the pharmaceutical industry.

Latest Patents

LeClercq's latest patents include innovative compositions that enhance the performance of pharmaceutical excipients. One of his notable patents is for microcrystalline cellulose and calcium phosphate compositions, which are useful as excipients in the preparation of solid dosage forms containing active pharmaceutical ingredients. These compositions improve recompactibility, particularly when using calcium phosphate with a small particle size. Another significant patent involves coprocessed compositions of microcrystalline cellulose and calcium carbonate, which also serve as excipients. These compositions exhibit improved recompactibility compared to those with lower ratios of microcrystalline cellulose to calcium carbonate.

Career Highlights

Bruno LeClercq is currently employed at Fmc Corporation, where he continues to innovate in the field of pharmaceutical formulations. His expertise in excipient development has positioned him as a valuable asset in the industry.

Collaborations

LeClercq collaborates with talented professionals such as Gregory Thoorens and Thomas A Ruszkay. Their combined efforts contribute to advancing the field of pharmaceutical excipients and enhancing drug formulation processes.

Conclusion

Bruno LeClercq's contributions to pharmaceutical excipients through his innovative patents demonstrate his commitment to improving drug formulation. His work continues to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…